Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(67%)

Phase Distribution

Ph not_applicable
1
33%
Ph early_phase_1
2
67%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(2)

Detailed Status

Terminated2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
33.3%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 12 (66.7%)
N/A1 (33.3%)

Trials by Status

completed133%
terminated267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Effect of Omega-3 Supplementation on Fasting Triglycerides During Lifestyle Intervention in Adults With Mild-to-moderate Hypertriglyceridemia

NCT05015348
terminatedearly_phase_1

Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MDD

NCT03101540
terminatedearly_phase_1

Open Trial Determining Antidepressant Effects of Omega-3 Supplementation During Pregnancy

NCT03101527

Clinical Trials (3)

Showing 3 of 3 trials
NCT05015348Not Applicable

Effect of Omega-3 Supplementation on Fasting Triglycerides During Lifestyle Intervention in Adults With Mild-to-moderate Hypertriglyceridemia

Completed
NCT03101540Early Phase 1

Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MDD

Terminated
NCT03101527Early Phase 1

Open Trial Determining Antidepressant Effects of Omega-3 Supplementation During Pregnancy

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
3